DK0413343T3 - Furanderivater - Google Patents

Furanderivater

Info

Publication number
DK0413343T3
DK0413343T3 DK90115731.3T DK90115731T DK0413343T3 DK 0413343 T3 DK0413343 T3 DK 0413343T3 DK 90115731 T DK90115731 T DK 90115731T DK 0413343 T3 DK0413343 T3 DK 0413343T3
Authority
DK
Denmark
Prior art keywords
furan derivatives
gastrointestinal
enterokinetic
expected
activity
Prior art date
Application number
DK90115731.3T
Other languages
English (en)
Inventor
Setsuya Sasho
Shunji Ichikawa
Hiromasa Kato
Hiroyuki Obase
Katsuichi Shuto
Yoshimasa Oiji
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Application granted granted Critical
Publication of DK0413343T3 publication Critical patent/DK0413343T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
DK90115731.3T 1989-08-17 1990-08-16 Furanderivater DK0413343T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21192089 1989-08-17

Publications (1)

Publication Number Publication Date
DK0413343T3 true DK0413343T3 (da) 1995-12-11

Family

ID=16613857

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90115731.3T DK0413343T3 (da) 1989-08-17 1990-08-16 Furanderivater

Country Status (10)

Country Link
US (1) US5075301A (da)
EP (1) EP0413343B1 (da)
JP (1) JPH0730064B2 (da)
AT (1) ATE125805T1 (da)
CA (1) CA2023311C (da)
DE (1) DE69021294T2 (da)
DK (1) DK0413343T3 (da)
ES (1) ES2075098T3 (da)
GR (1) GR3017870T3 (da)
HK (1) HK1006459A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds
US5338871A (en) * 1991-12-20 1994-08-16 Torcan Chemical Ltd. Preparation of form 1 ranitidine hydrochloride
AU662454B2 (en) * 1992-05-12 1995-08-31 Zeria Pharmaceutical Co., Ltd. Novel quaternary ammonium salts and use thereof as medicine
CA2219747C (en) * 1995-05-18 2008-11-25 Zeria Pharmaceutical Co., Ltd. Aminothiazole derivative, medicament containing the same, and intermediate for preparation of said compound
US6121301A (en) * 1996-10-24 2000-09-19 Zeria Pharmaceutical Co., Ltd. Substituted benzoylaminothiazole derivatives and drugs containing the same
US6152966A (en) * 1998-05-13 2000-11-28 Novo Nordisk A/S Treatment of cork with a phenol oxidizing enzyme
US6362205B2 (en) 1998-11-05 2002-03-26 Novo Nordisk A/S Substituted 3,3-diamino-2-propenenitriles, their preparation and use
AU6327199A (en) 1998-11-05 2000-05-29 Novo Nordisk A/S Substituted 3,3-diamino-2-propenenitriles, their preparation and use
KR20060123210A (ko) * 2003-12-04 2006-12-01 에프엠씨 코포레이션 살충성 n-(헤테로아릴알킬)알칸다이아민 유도체
CN111303087B (zh) * 2020-04-07 2021-08-10 自然资源部第三海洋研究所 呋喃酮类化合物及其制备方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4048058A (en) * 1975-08-13 1977-09-13 Standard Oil Company (Indiana) Methods to be used in reforming processes employing multi-metallic catalysts
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
FI832520A7 (fi) * 1982-07-12 1984-01-13 Bristol Myers Co Farmaseuttisia menetelmiä ja koostumuksia.
US4458077A (en) * 1982-11-22 1984-07-03 American Home Products Corporation Heterocyclic anti-ulcer agents
GB2209163B (en) * 1987-08-28 1991-04-24 Toyama Chemical Co Ltd Amine derivative and its salt, process for producing the same, and anti-ulcer agent containing the same

Also Published As

Publication number Publication date
CA2023311C (en) 1999-11-02
EP0413343A2 (en) 1991-02-20
DE69021294D1 (de) 1995-09-07
EP0413343B1 (en) 1995-08-02
JPH03163074A (ja) 1991-07-15
JPH0730064B2 (ja) 1995-04-05
US5075301A (en) 1991-12-24
EP0413343A3 (en) 1992-04-22
GR3017870T3 (en) 1996-01-31
DE69021294T2 (de) 1996-01-25
ATE125805T1 (de) 1995-08-15
CA2023311A1 (en) 1991-02-18
HK1006459A1 (en) 1999-02-26
ES2075098T3 (es) 1995-10-01

Similar Documents

Publication Publication Date Title
LU90219I2 (fr) Tolcapone et ses dérivés pharmaceutiquement acceptables (TASMAR)
LU91039I2 (fr) Proteq flu et ses dérivés pharmaceutiquement acceptables
LV10442A (lv) Panemiens pirimidina atvasinajumu iegusanai
KR870700602A (ko) 메바로노락톤 및 그것의 유도체의 헤테로사이클릭 유사체 및 그것의 생산방법 및 약학적인 그것의 용도
LU90484I2 (fr) Novorapid - insuline asparte et ses sels et derives pharmaceutiquement acceptables
LV10082A (lv) Propenskabes atvasinajumi to iegusanas panemiens sastavs un pielietosana senisu kukainu un ercu apkarosanai
LU88790I2 (fr) Moxidectin et ses dérivés pharmaceutiquement acceptables
DE69021294D1 (de) Furanderivate.
KR910700046A (ko) 포르피린의 생산 및 용도
FI895447A7 (fi) Substituoidut terapeuttisina aineina käytettävät adeniinijohdannaiset
FI924478L (fi) 24-oxa-derivat i vitamin d-serien
FR2623806B1 (fr) Esters d'acides 3,6-dihydro-1,5(2h)-pyrimidinecarboxyliques a action therapeutique
LU88843I2 (fr) Ropivacaine et ses dérivés pharmaceutiquement acceptables (Naropine R)
LV10436A (lv) Azola atvasinajumi un to iegusanas starpprodukti
LV10074A (lv) Aizvietoti bicikloheptadiona atvasinajumi un to iegusanas panemiens un herbicidi
IT8822760A0 (it) Ciclodestrinclatrati di derivati della 5-ciano-prostaciclina e loro impiego come medicinali
JPS5419959A (en) Novel daunobicine derivative * production thereof and use of same as drug
DK329189A (da) Glycerolderivat og dets farmakologiske anvendelse
SE7902915L (sv) 4-oxo-4h-pyrido(1,2-a)pyrimidin-3-n-(1h-tetrazol-5-yl) karboxamidderivat och deras anvendning sasom inhibitorer av allergiska reaktioner
LU90110I2 (fr) Penciclovir et ses dérivés pharmaceutiquement acceptables
BE859290A (fr) Preparation d'acides alpha-cetocarboxyliques aliphatiques et heterocycliques
DK283586A (da) Penemderivater
FI893233A7 (fi) THAZ-johdannaisia aivotoiminnan parantamiseksi
KR920007626A (ko) 벤조[b]티오펜-2-카르복시이미드아미드 유도체의 사용방법
IT1095602B (it) Derivati d'acidi furoil-o tenoil-naftilossialchil-carbossilio i,loro preparazione e loro impiego come medicamenti